Dr L. Syd M Johnson joins Ethics Talk to discuss her article, coauthored with Drs Hope Ferdowsian and Jessica Pierce: “How One Health Instrumentalizes Nonhuman Animals.”
Developing drugs for profit is challenged in Parasites!, a patient education comic that highlights the need for unprofitable drugs for tropical diseases.
AMA J Ethics. 2018;20(2):167-175. doi:
10.1001/journalofethics.2018.20.2.msoc1-1802.
AMA Journal of Ethics editor Audiey Kao, MD, PhD, interviewed Richard Pan, MD, MPH, about how, as a physician and legislator, he seeks to protect public health in light of recurrent outbreaks of vaccine-preventable infectious diseases.
Levan Atanelov, MD, MS, Steven A. Stiens, MD, MS, and Mark A. Young, MD, MBA
Physical medicine and rehabilitation has developed into a medical specialty that aims to restore optimal patient function in multiple dimensions of life with an interdisciplinary approach to care delivery.
AMA J Ethics. 2015;17(6):568-574. doi:
10.1001/journalofethics.2015.17.6.mhst1-1506.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.
Patients who have been encouraged to think of themselves as consumers and a medical system that is driven by individual demands rather than big-picture planning can undermine fairness in the distribution of vaccines.
A much-anticipated attempt to rectify the many shortcomings in public health statutory law and regulations, the Turning Point Act resulted in sweeping overhauls of public health infrastructure and legislation in several states.
Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets.